secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dare Bioscience, Inc. (DARE)
CIK:        0001401914
Form:       8-K
Filed at:   2022-12-16T23:59:59+00:00
Accession:  0001493152-22-035781
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Dare Bioscience receives Nasdaq deficiency notice for stock price below $1.00
-----------------------------------------------------------------------------

- Nasdaq notified Dare on Dec 16, 2022 that its common stock closed below $1.00 for 30 consecutive business days.
- The company has 180 calendar days, until June 14, 2023, to regain compliance with the minimum bid price rule.
- Compliance can be achieved if closing bid price is at least $1.00 for 10 consecutive business days.
- If not compliant by June 14, 2023, Dare may be eligible for an additional 180-day period subject to meeting other standards.
- Failure to regain compliance could result in delisting from Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401914/000149315222035781/0001493152-22-035781-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401914/000149315222035781/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-035781

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer